Macrophages, Chronic Inflammation, and Insulin Resistance

被引：114

作者：

Li, He ^{[1
]}

Meng, Ya ^{[1
]}

He, Shuwang ^{[2
]}

Tan, Xiaochuan ^{[1
]}

Zhang, Yujia ^{[1
]}

Zhang, Xiuli ^{[1
]}

Wang, Lulu ^{[3
,4
]}

Zheng, Wensheng ^{[1
,4
]}

机构：

[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Beijing City Key Lab Drug Delivery Technol & Nove, Beijing 100050, Peoples R China

[2] Shandong DYNE Marine Biopharmaceut Co Ltd, Rongcheng 264300, Peoples R China

[3] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Beijing 100050, Peoples R China

[4] 1 Xian Nong Tan St, Beijing 100050, Peoples R China

来源：

CELLS | 2022年 / 11卷 / 19期

关键词：

obesity; macrophages; chronic inflammation; insulin resistance; molecular mechanism; TUMOR-NECROSIS-FACTOR; ALTERNATIVELY ACTIVATED MACROPHAGES; ADIPOSE-TISSUE INFLAMMATION; DIET-INDUCED OBESITY; N-TERMINAL KINASE; SKELETAL-MUSCLE INFLAMMATION; LOW-GRADE INFLAMMATION; TNF-ALPHA ANTIBODY; PPAR-GAMMA; IMMUNE CELLS;

D O I：

10.3390/cells11193001

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The prevalence of obesity has reached alarming levels, which is considered a major risk factor for several metabolic diseases, including type 2 diabetes (T2D), non-alcoholic fatty liver, atherosclerosis, and ischemic cardiovascular disease. Obesity-induced chronic, low-grade inflammation may lead to insulin resistance, and it is well-recognized that macrophages play a major role in such inflammation. In the current review, the molecular mechanisms underlying macrophages, low-grade tissue inflammation, insulin resistance, and T2D are described. Also, the role of macrophages in obesity-induced insulin resistance is presented, and therapeutic drugs and recent advances targeting macrophages for the treatment of T2D are introduced.

引用

页数：24

共 50 条

[21] Inflammation and Insulin Resistance as Novel Mechanisms of Wasting in Chronic Dialysis Patients
da Costa, Jose Abrao Cardeal
Ikizler, T. Alp
SEMINARS IN DIALYSIS, 2009, 22 (06) : 652 - 657
[22] Swimming intervention alleviates insulin resistance and chronic inflammation in metabolic syndrome
Tan, Jiye
Guo, Lili
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (01) : 57 - 62
[23] The Impact of Insulin Resistance and Chronic Kidney Disease on Inflammation and Cardiovascular Disease
Kosmas, Constantine E.
Silverio, Delia
Tsomidou, Christiana
Salcedo, Maria D.
Montan, Peter D.
Guzman, Eliscer
CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2018, 11
[24] Insulin resistance influences hepatic inflammation in patients with chronic hepatitis C
Ario, Keisuke
Mizuta, Toshihiko
Eguchi, Yuichiro
Kumagai, Takanori
Yasmake, Tsutomu
Ozaki, Iwata
Fujimoto, Kazuma
GASTROENTEROLOGY, 2006, 130 (04) : A769 - A770
[25] Obesity and Insulin Resistance: Associations with Chronic Inflammation, Genetic and Epigenetic Factors
Gasmi, Amin
Noor, Sadaf
Menzel, Alain
Dosa, Alexandru
Pivina, Lyudmila
Bjorklund, Geir
CURRENT MEDICINAL CHEMISTRY, 2021, 28 (04) : 800 - 826
[26] Inflammation, Insulin Resistance, and Atherosclerosis
Theuma, Pierre
Fonseca, V. A.
METABOLIC SYNDROME AND RELATED DISORDERS, 2004, 2 (02) : 105 - +
[27] Nuts, inflammation and insulin resistance
Casas-Agustench, Patricia
Bullo, Monica
Salas-Salvado, Jordi
ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2010, 19 (01) : 124 - 130
[28] Inflammation and insulin resistance in uremia
Zanetti, Michda
Barazzoni, Rocco
Guarnieri, Gianfianco
JOURNAL OF RENAL NUTRITION, 2008, 18 (01) : 70 - 75
[29] Microbiome, inflammation and insulin resistance
Fangmann, Daniela
Stuermer, Paula
Laudes, Matthias
DIABETOLOGE, 2019, 15 (04): : 318 - 324
[30] Obesity, inflammation, and insulin resistance
Martins, Luana Mota
Soares Oliveira, Ana Raquel
Climaco Cruz, Kyria Jayanne
Torres-Leal, Francisco Leonardo
Marreiro, Dilina do Nascimento
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 50 (04) : 677 - 692

← 1 2 3 4 5 →